# What's next for GLP-1 weight loss drugs?

Page: https://stenobird.com/podcast/beyond-lab-walls-salk-institute-6780063/what-s-next-for-glp-1-weight-loss-drugs
Text version: https://stenobird.com/podcast/beyond-lab-walls-salk-institute-6780063/what-s-next-for-glp-1-weight-loss-drugs.md
Podcast: [Beyond Lab Walls | Salk Institute](https://stenobird.com/podcast/beyond-lab-walls-salk-institute-6780063)
Published: 2026-01-26T21:35:00+00:00
Episode link: https://f6581ef4-4950-4497-9ce2-674af8984163.libsyn.com/whats-next-for-glp-1-weight-loss-drugs
Audio file: https://traffic.libsyn.com/secure/f6581ef4-4950-4497-9ce2-674af8984163/BLW-GLP1.mp3?dest-id=4348308
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/beyond-lab-walls-salk-institute-6780063/episodes/what-s-next-for-glp-1-weight-loss-drugs
Duration seconds: 1226

## Resource

Salk scientist Christian Metallo, PhD, weighs in on the pros and cons of GLP-1 drugs and gives us a sneak peek into how metabolism research at Salk could inspire the next generation of obesity and weight management treatments.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/beyond-lab-walls-salk-institute-6780063/episodes/what-s-next-for-glp-1-weight-loss-drugs/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/beyond-lab-walls-salk-institute-6780063/what-s-next-for-glp-1-weight-loss-drugs.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.